Sage Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
26.03.24
/
50%
€17.20
Target price
26.03.25
€26.71
Performance (%)
-37.62%
Price
16.05.24
€11.04
Summary
This prediction is currently active. Massive losses of -37.62% have been the result for the BUY prediction by JPMorgan_Chase___Co_. This prediction currently runs until 26.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sage Therapeutics Inc. | -0.090% | -0.090% |
iShares Core DAX® | -0.383% | 5.404% |
iShares Nasdaq 100 | 1.248% | 6.732% |
iShares Nikkei 225® | 0.525% | 1.840% |
iShares S&P 500 | 0.640% | 4.710% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target raised by analysts at JPMorgan Chase & Co. from $24.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for SAGE provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.59
01.05.24
01.05.24
€26.21
01.05.25
01.05.25
-12.31%
16.05.24
16.05.24